Ron van Schaik

Ron van Schaik

Professor of Pharmacogenetics, President of the European Society of Pharmacogenomic (Netherlands/Canada)

Ron H.N. van Schaik, most prominent professor of pharmacogenetics from Netherlands/Canada, will discuss about his areas of expertise in Congress Symposiums.

Prof. Ron H.N. van Schaik is a registered European Clinical Chemist (2003) and Full Professor Pharmacogenetics (2013). He is working at the department of Clinical Chemistry (AKC) at the Erasmus University Medical Center (Erasmus MC) in Rotterdam since 1998.

He studied chemistry at Utrecht University (specializations Biochemistry, Clinical Chemistry and Molecular Biology) and received his PhD in 1992. He was trained in molecular biology at Cold Spring Harbor Laboratories in New York. From 1992, he worked as post-doc at the Erasmus University (Dept. Endocrinology & Reproduction) and the Academic Hospital Rotterdam (Dept. Pathology, Dept. Clinical Chemistry) on translational research involving molecular biological testing. Currently, he is medical coordinator of the AKC units Specialized Research & Development (BO&O). He is Director of the National and International (IFCC) Expert Center Pharmacogenetics.

Prof. van Schaik leads a research group on pharmacogenetics, in which the translation to implementation for patient diagnostics is the main topic. Current lines of research include Transplantation/immunosuppression, Oncology, Psychiatry, Anesthesiology, Pain and Virology. He has published over 180 articles on pharmacogenetics (H-factor 46), and he participates in national (NVKC, KNMP) and international (IFCC, AACC, IATDMCT, EUSPM, Genomic Medicine Alliance, European Medicine Agency) advisory committees on this topic. As a second line of research, he is involved in studies on new markers for the detection of prostate cancer.

In 2001, Prof. van Schaik received the Ortho Clinical Diagnostics Award of the Dutch Society for Clinical Chemistry for outstanding research. In 2008, the Pharmacogenetics Core Laboratory AKC got internationally recognized by the International Federation of Clinical Chemistry (IFCC) as a Reference Laboratory for Pharmacogenetics.


Alfa Hall

CHAIR Artūras Petronis (Canada) CO-CHAIR Ron van Schaik (Netherlands/Canada) SPEAKER THEMES Ron van Schaik (Netherlands/Canada): Pharmacogenetics: do You Have Your DNA-Passport? Eglė Preikšaitienė (Lithuania): Genomic Alterations and Intellectual Disability: Unigene Results. Virginija Adomaitienė (Lithuania): Interface of Polymorphisms of Serotoninergic System Genes with an Attempt to Commit Suicide. DESCRIPTION To be confirmed.